Overview
Syai Health,
headquartered in Singapore, is a biotechnology company specializing in
AI-empowered medical devices for chronic disease management. Established in
2016 by a team from Oxford and Cambridge, Syai integrates advanced biosensing
technology with artificial intelligence to provide innovative solutions for
conditions like diabetes. The company aims to revolutionise home-based health
management through user-centric products that enhance patient care and
engagement.
Expertise in Chronic Disease Management
Syai Health focuses on developing advanced tools for chronic disease
management, particularly in diabetes care. Key products include:
- Syai Tag: A mini, real-time, wearable continuous glucose monitor (CGM) that
provides real-time glucose readings every five minutes. The device is
designed for comfort and discretion, with a coin-sized biosensor that is
durable for 14 days. It allows users to monitor glucose levels, trends,
and fluctuations, aiding in better glucose management.
- Syai Hub: A high-performance BLE LTE gateway with a slim design, facilitating
remote and hospitalized patient monitoring solutions. It ensures seamless
connectivity to wearable medical devices like the Syai CGM, enhancing data
transmission and accessibility.
- Syai Link: An application that enables users
to share their glucose data with loved ones and caregivers, providing an
extra layer of support and engagement in diabetes management.
These products are designed to integrate seamlessly into users' daily
routines, promoting proactive health management and improved quality of life.
Global Presence
Syai Health has
established a significant global footprint through strategic partnerships and
collaborations. The company has secured funding from prominent investors,
including AstraZeneca and Xiaomi Corporation, to support its research and
development activities. Syai's products are gaining recognition worldwide, and
they plan to expand their availability in various markets.
Partnership with JAT
Medical
Syai Health
collaborates with JAT Medical in Saudi Arabia to introduce its innovative
chronic disease management solutions to the region. This partnership aims to
provide healthcare professionals and patients with advanced tools like the Syai
Tag CGM, enhancing diabetes care and patient outcomes in the Kingdom.
Achievements
Syai Health's
commitment to innovation and design excellence has been recognized through
various accolades:
- Red Dot Design Award 2024: The Syai Tag CGM received this
prestigious award for its outstanding design and innovative approach to
healthcare technology.
- Strategic Investments: Secured significant funding from
leading investors like AstraZeneca and Xiaomi Corporation, underscoring
confidence in Syai's vision and technological capabilities.
Syai Health is poised to transform chronic disease management through
continuous innovation and a patient-centric approach, empowering individuals to
lead healthier lives.